Effects of MRI contrast agents on human embryonic lung fibroblasts

Investigative Radiology

Volumn 45, Issue 9, 2010, Pages 513-519

  Wiesinger, Benjamin ^a   Kehlbach, Rainer ^a   Bebin, Julie ^a   Hemsen, Jennifer ^a   Bantleon, Rüdiger ^a   Schmehl, Jörg ^a   Dietz, Klaus ^a   Claussen, Claus D ^a   Wiskirchen, Jakub ^b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Franziskus Krankenhaus   (Germany)

Author keywords

contrast media; fetal embryonic fibroblasts; magnetic resonance tomography; toxicity

Indexed keywords

FERUCARBOTRAN; GADOBUTROL; GADOLINIUM; GADOLINIUM PENTETATE; MANGAFODIPIR; TETRAMETHYLRHODAMINE ETHYL ESTER; VIMENTIN;

APOPTOSIS; ARTICLE; CELL COUNT; CELL CULTURE; CELL CYCLE S PHASE; CELL SELECTION; CELL STRUCTURE; CELL VIABILITY; CELLULAR DISTRIBUTION; COLONY FORMATION; CONTROL GROUP; CONTROLLED STUDY; CYTOMETRY; EMBRYO; HUMAN; HUMAN CELL; HUMAN EMBRYONIC LUNG FIBROBLAST; IMMUNOFLUORESCENCE; INCUBATION TIME; KINETICS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STAINING;

EID: 77955469467     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181eb2fe7     Document Type: Article

References (32)

1. Tanaka YO, Sohda S, Shigemitsu S, et al. High temporal resolution dynamic contrast MRI in a high risk group for placenta accreta. Magn Reson Imaging. 2001;19:635-642.
2. Marcos HB, Semelka RC, Worawattanakul S. Normal placenta: gadoliniumenhanced dynamic MR imaging. Radiology. 1997;205:493-496. (Pubitemid 27467331)
3. Erickson ML, Johnson R, Bannykh SI, et al. Malignant rhabdoid tumor in a pregnant adult female: literature review of central nervous system rhabdoid tumors. J Neurooncol. 2005;74:311-319.
4. Wittich AC, Salminen ER, Yancey MK, et al. Myomectomy during early pregnancy. Mil Med. 2000;165:162-164.
5. Liu X, Ashtari M, Leonidas JC, et al. Magnetic resonance imaging of the fetus in congenital intrathoracic disorders: preliminary observations. Pediatr Radiol. 2001;31:435-439.
6. Lindl T, Lewandowski B, Schreyogg S, et al. An evaluation of the in vitro cytotoxicities of 50 chemicals by using an electrical current exclusion method versus the neutral red uptake and MTT assays. Altern Lab Anim. 2005;33:591-601.
7. Eriksson JE, Dechat T, Grin B, et al. Introducing intermediate filaments: from discovery to disease. J Clin Invest. 2009;119:1763-1771.
8. Maldjian C, Adam R, Pelosi M, et al. MRI appearance of placenta percreta and placenta accreta. Magn Reson Imaging. 1999;17:965-971.
9. Nicklas AH, Baker ME. Imaging strategies in the pregnant cancer patient. Semin Oncol. 2000;27:623-632.
10. Verswijvel G, Grieten M, Gyselaers W, et al. MRI in the assessment of pregnancy related intrauterine bleeding: a valuable adjunct to ultrasound? JBR-BTR. 2002;85:189-192.
11. Bailey W, Freidenberg GR, James HE, et al. Prenatal diagnosis of a craniopharyngioma using ultrasonography and magnetic resonance imaging. Prenat Diagn. 1990;10:623-629.
12. Heinrich MC, Kuhlmann MK, Kohlbacher S, et al. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study. Radiology. 2007;242:425-434.
13. Sadowski EA, Bennett LK, Chan MR, et al. Nephrogenic systemic fibrosis: risk factors and incidence estimation. Radiology. 2007;243:148-157.
14. Sieber MA, Pietsch H, Walter J, et al. A preclinical study to investigate the development of nephrogenic systemic fibrosis: a possible role for gadoliniumbased contrast media. Invest Radiol. 2008;43:338.
15. Steger-Hartmann T, Hofmeister R, Ernst R, et al. A review of Preclinical Safety Data for Magnevist (Gadopentetate dimeglumine) in the Context of Nephrogenic Systemic fibrosis (NSF). Invest Radiol. 2010;45:520-528.
16. Hope TA, Herfkens RJ, Denianke KS, et al. Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine. Invest Radiol. 2009;44:135-139.
17. Haylor J, Dencausse A, Vickers V, et al. Nephrogenic gadolinium biodistribution and skin cellularity following a single injection of omniscan in the rat. Invest Radiol. 2010;45:507-512.
18. Novak Z, Thurmond AS, Ross PL, et al. Gadolinium-DTPA transplacental transfer and distribution in fetal tissue in rabbits. Invest Radiol. 1993;28:828-830.
19. Okuda Y, Sagami F, Tirone P, et al. Reproductive and developmental toxicity study of gadobenate dimeglumine formulation (E7155) (3)\Study of embryo-fetal toxicity in rabbits by intravenous administration-in Japanese. J Toxicol Sci. 1999;24:79-87. (Pubitemid 30002832)
20. Spencer A, Wilson S, Harpur E. Gadolinium chloride toxicity in the mouse. Hum Exp Toxicol. 1998;17:633-637.
21. Greisberg JK, Wolf JM, Wyman J, et al. Gadolinium inhibits thymidine incorporation and induces apoptosis in chondrocytes. J Orthop Res. 2001;19:797-801.
22. Rofsky NM, Pizzarello DJ, Weinreb JC, et al. Effect on fetal mouse development of exposure to MR imaging and gadopentetate dimeglumine. J Magn Reson Imaging. 1994;4:805-807.
23. De Santis M, Straface G, Cavaliere AF, et al. Gadolinium periconceptional exposure: pregnancy and neonatal outcome. Acta Obstet Gynecol Scand. 2007;86:99-101.
24. Farrell E, Wielopolski P, Pavljasevic P, et al. Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun. 2008;369:1076-1081.
25. Lee ES, Chan J, Shuter B, et al. Microgel iron oxide nanoparticles for tracking human fetal mesenchymal stem cells through magnetic resonance imaging. Stem Cells. 2009;27:1921-1931.
26. Maxwell DJ, Bonde J, Hess DA, et al. Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells. Stem Cells. 2008;26:517-524.
27. Wu YJ, Muldoon LL, Varallyay C, et al. In vivo leukocyte labelling with intravenous ferumoxides/protamine sulphate complex and in vitro characterization for cellular magnetic resonance imaging. Am J Physiol Cell Physiol. 2007;293:1698-1708.
28. Crossgrove J, Zheng W. Manganese toxicity upon overexposure-review. NMR Biomed. 2004;17:544-553.
29. Grant D, Blazak WF, Brown GL. The reproductive toxicology of intravenously administered MnDPDP in the rat and rabbit. Acta Radiol. 1997;38:759-769.
30. Hahn G, Sorge I, Gruhn B, et al. Pharmacokinetics and safety of gadobutrol enhanced magnetic resonance imaging in pediatric patients. Invest Radiol. 2009;44:776-783.
31. Wiskirchen J, Grönewäller EF, Heinzelmann F, et al. human fetal lung firboblasts: in vitro study of repetitive magnetive field exposure at 0. 2, 1.0, and 1.5 T. Radiology. 2000;215:858-862.
32. Wiskirchen J, Groenewaeller EF, Kehlbach R, et al. Long-term effects of repetitive exposure to a static magnetic field (1.5 T) on proliferation of human fetal lung fibroblasts. Magn Reson Med. 1999;41:464-468.